Logo image of TENX

TENAX THERAPEUTICS INC (TENX) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:TENX - US88032L6056 - Common Stock

13.12 USD
+0.27 (+2.1%)
Last: 1/8/2026, 8:09:42 PM
Buy % Consensus

87

ChartMill assigns a Buy % Consensus number of 87% to TENX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 25.76. This target is 96.3% above the current price.
TENX was analyzed by 11 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about TENX.
In the previous month the buy percentage consensus was at a similar level.
TENX was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
TENX Historical Analyst RatingsTENX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -107 -97 -87 -77 -67 -57 -47 -37 -27 -17 -7 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 13.1220.2026.0125.7631.50 - 53.96% 98.25% 96.30% 140.09%
TENX Current Analyst RatingTENX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades
Date Firm Action Rating
2025-12-17 Guggenheim Maintains Buy -> Buy
2025-09-08 Piper Sandler Initiate Overweight
2025-08-14 Guggenheim Maintains Buy -> Buy
2024-10-24 Leerink Partners Initiate Outperform
2024-10-14 Guggenheim Initiate Buy
2024-09-30 William Blair Initiate Outperform
2024-02-20 Roth MKM Reiterate Buy -> Buy
2023-11-13 Roth MKM Reiterate Buy -> Buy
2023-03-07 Roth MKM Initiate Buy

TENAX THERAPEUTICS INC / TENX FAQ

What is the average price target for TENAX THERAPEUTICS INC (TENX) stock?

11 analysts have analysed TENX and the average price target is 25.76 USD. This implies a price increase of 96.3% is expected in the next year compared to the current price of 13.12.


What is the consensus rating for TENAX THERAPEUTICS INC (TENX) stock?

The consensus rating for TENAX THERAPEUTICS INC (TENX) is 87.2727 / 100 . This indicates that analysts generally have a positive outlook on the stock.